Literature DB >> 2455895

Interaction of an immunodominant epitope with Ia molecules in T-cell activation.

L Adorini1, A Sette, S Buus, H M Grey, M Darsley, P V Lehmann, G Doria, Z A Nagy, E Appella.   

Abstract

The amino acid sequence corresponding to residues 107-116 of hen egg-white lysozyme (HEL) has been identified as containing an immunodominant T-cell epitope recognized in association with the I-Ed molecule. The immunodominance of this epitope in HEL-primed H-2d mice was demonstrated by analysis of the T-cell proliferative response induced by synthetic peptides covering almost the entire HEL sequence. All the T-cell hybridomas from H-2d mice analyzed recognize the HEL sequence 107-116 in association with the I-Ed molecule. Correlating with the restriction of T-cell recognition, HEL-(105-120)-peptide binds to I-Ed but not to I-Ad molecules. Conservative or semiconservative substitutions at positions 113 (Asn----Lys), 114 (Arg----His), or 115 (Cys----Ala) abrogate the ability of HEL-(105-120) to activate T cells. Substitutions at residues 113 and 115 affect T-cell recognition but not the binding to I-Ed molecules, whereas, as shown by binding data and competition experiments, an Arg----His substitution at position 114 profoundly impairs the capacity of the peptide to interact with I-Ed molecules. In agreement with these results, [Lys113]HEL-(105-120)-peptide but not [His114]HEL-(105-120)-peptide was found to be immunogenic in H-2d mice. Thus, a single semiconservative substitution drastically reduces binding capacity and abolishes immunogenicity, suggesting that a strict correlation exists between binding of a peptide to Ia molecules and its immunogenicity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455895      PMCID: PMC281712          DOI: 10.1073/pnas.85.14.5181

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  The T cell receptor: the alpha and beta chains define idiotype, and antigen and MHC specificity.

Authors:  J Yagüe; J White; C Coleclough; J Kappler; E Palmer; P Marrack
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

2.  Oligopeptide antigens of the angiotensin lineage compete for presentation by paraformaldehyde-treated accessory cells to T cells.

Authors:  S Buus; O Werdelin
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

3.  Binding of immunogenic peptides to Ia histocompatibility molecules.

Authors:  B P Babbitt; P M Allen; G Matsueda; E Haber; E R Unanue
Journal:  Nature       Date:  1985 Sep 26-Oct 2       Impact factor: 49.962

4.  Prediction of protein antigenic determinants from amino acid sequences.

Authors:  T P Hopp; K R Woods
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

Review 5.  The interaction between protein-derived immunogenic peptides and Ia.

Authors:  S Buus; A Sette; H M Grey
Journal:  Immunol Rev       Date:  1987-08       Impact factor: 12.988

6.  Requirements for the processing of antigen by antigen-presenting B cells. II. Biochemical comparison of the fate of antigen in B cell tumors and macrophages.

Authors:  H M Grey; S M Colon; R W Chesnut
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

7.  Synthesis of the antibacterial peptide cecropin A (1-33).

Authors:  R B Merrifield; L D Vizioli; H G Boman
Journal:  Biochemistry       Date:  1982-09-28       Impact factor: 3.162

8.  A microcomputer program for probit analysis of interleukin-2 (IL-2) titration data.

Authors:  A Sette; L Adorini; E Marubini; G Doria
Journal:  J Immunol Methods       Date:  1986-02-12       Impact factor: 2.303

9.  Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing.

Authors:  R Shimonkevitz; J Kappler; P Marrack; H Grey
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

10.  Inhibition of antigen-specific T lymphocyte activation by structurally related Ir gene-controlled polymers. Evidence of specific competition for accessory cell antigen presentation.

Authors:  K L Rock; B Benacerraf
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

View more
  20 in total

1.  Abortive activation of CD4 T cell responses during competitive priming in vivo.

Authors:  Jason M Weaver; Francisco A Chaves; Andrea J Sant
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-07       Impact factor: 11.205

2.  Self peptide requirement for class II major histocompatibility complex allorecognition.

Authors:  S Demotz; A Sette; K Sakaguchi; R Buchner; E Appella; H M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

3.  Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis.

Authors:  A Sette; S Buus; E Appella; J A Smith; R Chesnut; C Miles; S M Colon; H M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice.

Authors:  J C Guery; F Galbiati; S Smiroldo; L Adorini
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

5.  Enhancement of peptide antigen presentation by a second peptide.

Authors:  A I de Kroon; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

6.  H-2b restriction of the immune response to the p126 Plasmodium falciparum antigen.

Authors:  D M Banic; P Delplace; C Mazingue; D Camus
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

7.  Mapping the sensitivity of T cells with an optical trap: polarity and minimal number of receptors for Ca(2+) signaling.

Authors:  X Wei; B J Tromberg; M D Cahalan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

8.  Minimum length of an idiotypic peptide and a model for its binding to a major histocompatibility complex class II molecule.

Authors:  B Bogen; J D Lambris
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

9.  Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.

Authors:  J C Guéry; A Sette; J Leighton; A Dragomir; L Adorini
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

10.  The peptide specificity of the endogenous T follicular helper cell repertoire generated after protein immunization.

Authors:  Scott A Leddon; Andrea J Sant
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.